CVA Family Office’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527K | Sell |
1,299
-231
| -15% | -$93.7K | 0.07% | 161 |
|
|
2025
Q1 | $761K | Buy |
1,530
+84
| +6% | +$41.8K | 0.12% | 116 |
|
|
2024
Q4 | $752K | Buy |
1,446
+69
| +5% | +$35.9K | 0.12% | 114 |
|
|
2024
Q3 | $852K | Hold |
1,377
| – | – | 0.14% | 104 |
|
|
2024
Q2 | $762K | Hold |
1,377
| – | – | 0.14% | 107 |
|
|
2024
Q1 | $800K | Sell |
1,377
-32
| -2% | -$18.6K | 0.14% | 102 |
|
|
2023
Q4 | $748K | Sell |
1,409
-69
| -5% | -$36.6K | 0.15% | 100 |
|
|
2023
Q3 | $748K | Buy |
1,478
+150
| +11% | +$75.9K | 0.17% | 97 |
|
|
2023
Q2 | $693K | Buy |
1,328
+26
| +2% | +$13.6K | 0.15% | 99 |
|
|
2023
Q1 | $750K | Buy |
1,302
+4
| +0.3% | +$2.31K | 0.17% | 91 |
|
|
2022
Q4 | $715K | Sell |
1,298
-114
| -8% | -$62.8K | 0.17% | 89 |
|
|
2022
Q3 | $716K | Sell |
1,412
-250
| -15% | -$127K | 0.19% | 85 |
|
|
2022
Q2 | $903K | Buy |
1,662
+345
| +26% | +$187K | 0.25% | 71 |
|
|
2022
Q1 | $778K | Sell |
1,317
-70
| -5% | -$41.4K | 0.19% | 80 |
|
|
2021
Q4 | $925K | Buy |
1,387
+528
| +61% | +$352K | 0.23% | 69 |
|
|
2021
Q3 | $379K | Sell |
859
-433
| -34% | -$191K | 0.27% | 62 |
|
|
2021
Q2 | $652K | Buy |
1,292
+128
| +11% | +$64.6K | 0.19% | 78 |
|
|
2021
Q1 | $531K | Buy |
1,164
+305
| +36% | +$139K | 0.2% | 72 |
|
|
2020
Q4 | $400K | Hold |
859
| – | – | 0.25% | 64 |
|
|
2020
Q3 | $379K | Buy |
859
+160
| +23% | +$70.6K | 0.27% | 62 |
|
|
2020
Q2 | $253K | Buy |
699
+200
| +40% | +$72.4K | 0.21% | 74 |
|
|
2020
Q1 | $142K | Buy |
+499
| New | +$142K | 0.14% | 90 |
|